Page last updated: 2024-11-03

risperidone and Coronary Stenosis

risperidone has been researched along with Coronary Stenosis in 1 studies

Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.

Coronary Stenosis: Narrowing or constriction of a coronary artery.

Research Excerpts

ExcerptRelevanceReference
"Pulmonary embolism was seen in our patient a week after starting risperidone."1.48Pseudo-Wellens' syndrome in pulmonary embolism. ( Basnyat, S; Bhattacharya, PT; Sedhai, YR, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sedhai, YR1
Basnyat, S1
Bhattacharya, PT1

Other Studies

1 other study available for risperidone and Coronary Stenosis

ArticleYear
Pseudo-Wellens' syndrome in pulmonary embolism.
    BMJ case reports, 2018, Dec-19, Volume: 11, Issue:1

    Topics: Antipsychotic Agents; Chest Pain; Coronary Stenosis; Electrocardiography; Humans; Male; Pulmonary Em

2018